Essity launches Issviva, a new product brand, online resource and e-commerce platform for those experiencing menopause; range comprises vitamins, supplements and intimate hygiene products to complement Essity's current incontinence, feminine care brands

Sample article from our Tissue & Hygiene

October 7, 2022 (press release) –

In conjunction with World Menopause Day on October 18, the hygiene and health company Essity is launching a new product area and the new product brand Issviva for women+ experiencing menopause – aimed at raising awareness and breaking the taboo surrounding this transition that impacts millions of women around the world. 

Issviva is an innovative global e-commerce platform that provides knowledge, solutions and products for women+ during the various stages of the menopause. Visitors can use forums to submit questions to experts and share experiences and lessons learned with others. There are also complete expert guides with articles and material aimed at teaching about and preparing for the transition, as well as products and services that help women+ by alleviating symptoms that normally appear during the different stages of the menopause. 

Issviva’s product range comprises vitamins, minerals, supplements and intimate hygiene products that complement Essity’s current brands in incontinence and feminine care.

In 2025, more than one billion women are expected to experience one of the phases associated with the menopause. Even though the menopause is a natural part of life, it is perceived as being a taboo subject with many preconceptions linked to fertility, sexuality and aging. In some parts of the world, the menopause is associated with disease or problems, and is often referred to sarcastically. A global survey of 15,000 respondents, conducted by Essity, also highlights significant knowledge gaps. For example, 41% of respondents state that they are knowledgeable or very knowledgeable about the menopause, though a full 75% gave the wrong answer or could not answer the false claim that menopausal women cannot become pregnant. Most of the respondents also said they would not speak out if a friend or family member mocked someone experiencing the menopause. 

“Essity is committed to breaking barriers to well-being, including stigmas and taboos around menopause. We have successfully worked for many years supporting women+ in different phases of life, providing feminine care products and incontinence products. Our extensive experience, good customer understanding and focus on education provide us with the knowledge and capacity to broaden our offering with our new brand Issviva,” says Cristina Arbelaez, Global Director New Menopause at Essity.

Issviva is currently available in the Brazilian market at issviva.com.br and the UK market at issviva.co.uk. Issviva will be launched in additional markets in the near future.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.